\-\ Texto\\:\\ \ \(0\)\
\-\ gen\\:\\ physical\\ exam\\ revealed\\ woman\\ appearing\\ stated\\ age\\.\\ \\ vital\\:\\ temperature\\ of\\ 98\\.9\\^f\\.\\ \\ bp\\=127\\/76\\,\\ hr\\=78\\,\\ resp\\=\\ 16\\.\\ \\ ent\\:\\ fundoscopic\\ exam\\ deferred\\.\\ \\ normal\\,\\ symmetrical\\ pinnae\\.\\ \\ pearly\\ grey\\ tm\\'s\\ w\\/o\\ effussion\\.\\ \\ no\\ palpable\\ tyroid\\ massess\\.\\ \\ heart\\:\\ \\ rrr\\.\\ \\ no\\ s3\\,\\ gallops\\,\\ murmurs\\,\\ or\\ rubs\\ auscultated\\.\\ \\ chest\\:\\ mild\\ wheezing\\ auscultated\\ throughout\\ lungs\\ bilaterally\\.\\ \\ abdominal\\:\\ \\ abdominal\\ bruits\\ auscultated\\ in\\ all\\ 4\\ quadrants\\.\\ \\ no\\ pallpable\\ masses\\ or\\ organomegaly\\.\\ \\ gu\\:\\ deferred\\.\\ \\ derm\\:\\ small\\ scattered\\ nodules\\ on\\ lower\\ extremeties\\.\\ \\ osteopathic\\:\\ left\\ rib\\ 2\\ elevated\\.\ \(0\)\
\-\ pt\\.\\ declined\\ trial\\ of\\ low\\ dose\\ prednisone\\ at\\ this\\ time\\,\\ due\\ to\\ the\\ fact\\ she\\ felt\\ her\\ symptoms\\ resolving\\,\\ as\\ well\\ as\\ fear\\ of\\ medication\\ side\\ effects\\.\\ \\ treatment\\ focused\\ on\\ pt\\ education\\.\ \(0\)\
\-\ bilateral\\ hilar\\ lymphadenopathy\\.\\ \\ paratracheal\\ adenopathy\\.\\ \\ parenchymal\\ infiltration\\.\\ \\ no\\ evidence\\ of\\ honeycombing\\,\\ hilar\\ retraction\\,\\ volume\\ loss\\,\\ or\\ bollus\\ change\\,\\ indicating\\ new\\ onset\\.\ \(0\)\
\-\ sarcoidosis\ \(108\)\
\-\ sarcoidosis\ \(108\)\
\-\ tuberculosis\ \(73\)\
\-\ lymphoma\ \(373\)\
\-\ berylliosis\ \(1\)\
\-\ asthma\ \(67\)\
\-\ 24\\ y\\/o\\ black\\ female\\ presents\\ with\\ upper\\ left\\ rib\\ pain\\,\\ and\\ a\\ persistant\\ cough\\ for\\ about\\ a\\ month\\.\\ \\ she\\ also\\ inquires\\ about\\ \\"marks\\"\\ on\\ her\\ lower\\ extremities\\.\ \(0\)\
\-\ roentgenographic\\ stage\\ 2\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ auscultated\\:\\ 0\\.30317792491229445\ \(0\)\
\-\ deferred\\:\\ 0\\.21787936950456063\ \(0\)\
\-\ hilar\\:\\ 0\\.14731492865125928\ \(0\)\
\-\ rib\\:\\ 0\\.14674594921084053\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.13608784542078817\ \(0\)\
\-\ tyroid\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ massess\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ pallpable\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ osteopathic\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ bollus\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ inquires\\:\\ 0\\.12846115228256663\ \(0\)\
\-\ pinnae\\:\\ 0\\.12275148905043508\ \(0\)\
\-\ effussion\\:\\ 0\\.12275148905043508\ \(0\)\
\-\ roentgenographic\\:\\ 0\\.12275148905043508\ \(0\)\
\-\ about\\:\\ 0\\.12027203185312907\ \(0\)\
\-\ derm\\:\\ 0\\.11870041851742347\ \(0\)\
\-\ pt\\:\\ 0\\.11561802147532815\ \(0\)\
\-\ pearly\\:\\ 0\\.11299075528529191\ \(0\)\
\-\ fear\\:\\ 0\\.11299075528529191\ \(0\)\
\-\ berylliosis\\:\\ 0\\.1108200420692413\ \(0\)\
\-\ marks\\:\\ 0\\.1108200420692413\ \(0\)\
\-\ extremeties\\:\\ 0\\.10893968475228032\ \(0\)\
\-\ persistant\\:\\ 0\\.10579743032656504\ \(0\)\
\-\ no\\:\\ 0\\.10448634974798436\ \(0\)\
\-\ education\\:\\ 0\\.10445529503947289\ \(0\)\
\-\ fundoscopic\\:\\ 0\\.10105930830409815\ \(0\)\
\-\ honeycombing\\:\\ 0\\.10105930830409815\ \(0\)\
\-\ her\\:\\ 0\\.1003681245553097\ \(0\)\
\-\ s3\\:\\ 0\\.09917895098713717\ \(0\)\
\-\ declined\\:\\ 0\\.09603669656142187\ \(0\)\
\-\ she\\:\\ 0\\.09563408830909337\ \(0\)\
\-\ bruits\\:\\ 0\\.09534964507196657\ \(0\)\
\-\ focused\\:\\ 0\\.09534964507196657\ \(0\)\
\-\ quadrants\\:\\ 0\\.09469456127432972\ \(0\)\
\-\ tm\\:\\ 0\\.09406860212450709\ \(0\)\
\-\ gu\\:\\ 0\\.09234214537983004\ \(0\)\
\-\ symmetrical\\:\\ 0\\.09080442691814433\ \(0\)\
\-\ organomegaly\\:\\ 0\\.0903270333292903\ \(0\)\
\-\ grey\\:\\ 0\\.089418217221994\ \(0\)\
\-\ trial\\:\\ 0\\.089418217221994\ \(0\)\
\-\ retraction\\:\\ 0\\.089418217221994\ \(0\)\
\-\ paratracheal\\:\\ 0\\.08898489804219815\ \(0\)\
\-\ resolving\\:\\ 0\\.08856451571420647\ \(0\)\
\-\ abdominal\\:\\ 0\\.08786647593864857\ \(0\)\
\-\ ent\\:\\ 0\\.0855889113068234\ \(0\)\
\-\ prednisone\\:\\ 0\\.08461737009715874\ \(0\)\
\-\ or\\:\\ 0\\.08383351578682431\ \(0\)\
\-\ gallops\\:\\ 0\\.0834181980907728\ \(0\)\
\-\ effects\\:\\ 0\\.0834181980907728\ \(0\)\
\-\ wheezing\\:\\ 0\\.08313370837056343\ \(0\)\
\-\ black\\:\\ 0\\.08231317946280062\ \(0\)\
\-\ lower\\:\\ 0\\.08209487568270646\ \(0\)\
\-\ temperature\\:\\ 0\\.08179157308347128\ \(0\)\
\-\ exam\\:\\ 0\\.08087380259280863\ \(0\)\
\-\ rubs\\:\\ 0\\.08080297340751896\ \(0\)\
\-\ asthma\\:\\ 0\\.08010456107662581\ \(0\)\
\-\ stated\\:\\ 0\\.0794391571889716\ \(0\)\
\-\ gen\\:\\ 0\\.07922416427705499\ \(0\)\
\-\ infiltration\\:\\ 0\\.07922416427705499\ \(0\)\
\-\ murmurs\\:\\ 0\\.07705345106100438\ \(0\)\
\-\ fact\\:\\ 0\\.07705345106100438\ \(0\)\
\-\ indicating\\:\\ 0\\.07599682341604283\ \(0\)\
\-\ dose\\:\\ 0\\.07501397609400971\ \(0\)\
\-\ rrr\\:\\ 0\\.07485663633201559\ \(0\)\
\-\ medication\\:\\ 0\\.07424428932650895\ \(0\)\
\-\ on\\:\\ 0\\.07278084711228101\ \(0\)\
\-\ parenchymal\\:\\ 0\\.072159440780147\ \(0\)\
\-\ vital\\:\\ 0\\.07152786577294248\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.07068870403123596\ \(0\)\
\-\ felt\\:\\ 0\\.07057280409962133\ \(0\)\
\-\ volume\\:\\ 0\\.07057280409962133\ \(0\)\
\-\ scattered\\:\\ 0\\.0698967496917077\ \(0\)\
\-\ adenopathy\\:\\ 0\\.06756974450280724\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.06494030140136155\ \(0\)\
\-\ as\\:\\ 0\\.06454081140607335\ \(0\)\
\-\ appearing\\:\\ 0\\.0641870864595761\ \(0\)\
\-\ stage\\:\\ 0\\.06396876019169687\ \(0\)\
\-\ nodules\\:\\ 0\\.0638250674938711\ \(0\)\
\-\ of\\:\\ 0\\.06287894111130311\ \(0\)\
\-\ extremities\\:\\ 0\\.06104483203386083\ \(0\)\
\-\ change\\:\\ 0\\.06086990106133617\ \(0\)\
\-\ cough\\:\\ 0\\.059971954705408136\ \(0\)\
\-\ lungs\\:\\ 0\\.05928231441877698\ \(0\)\
\-\ throughout\\:\\ 0\\.05907673759694603\ \(0\)\
\-\ 24\\:\\ 0\\.05694982460967149\ \(0\)\
\-\ palpable\\:\\ 0\\.05643300468932718\ \(0\)\
\-\ heart\\:\\ 0\\.055853085475234175\ \(0\)\
\-\ new\\:\\ 0\\.055571842645101066\ \(0\)\
\-\ side\\:\\ 0\\.055492508563723404\ \(0\)\
\-\ left\\:\\ 0\\.05480292115881846\ \(0\)\
\-\ elevated\\:\\ 0\\.05476032318243025\ \(0\)\
\-\ masses\\:\\ 0\\.05468542001540775\ \(0\)\
\-\ bilaterally\\:\\ 0\\.05357265118664541\ \(0\)\
\-\ revealed\\:\\ 0\\.052670307964868004\ \(0\)\
\-\ onset\\:\\ 0\\.051580567370507355\ \(0\)\
\-\ age\\:\\ 0\\.05043039676093012\ \(0\)\
\-\ loss\\:\\ 0\\.048938454080142385\ \(0\)\
\-\ month\\:\\ 0\\.048864143816940875\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04783999731724627\ \(0\)\
\-\ all\\:\\ 0\\.047817044154546684\ \(0\)\
\-\ time\\:\\ 0\\.047612132115541224\ \(0\)\
\-\ due\\:\\ 0\\.04617374940608759\ \(0\)\
\-\ low\\:\\ 0\\.04609235171009102\ \(0\)\
\-\ evidence\\:\\ 0\\.045594006634175004\ \(0\)\
\-\ mild\\:\\ 0\\.04553537325786779\ \(0\)\
\-\ symptoms\\:\\ 0\\.04395065511712098\ \(0\)\
\-\ physical\\:\\ 0\\.043555411928612967\ \(0\)\
\-\ bilateral\\:\\ 0\\.04317096012115283\ \(0\)\
\-\ upper\\:\\ 0\\.04292576944268122\ \(0\)\
\-\ chest\\:\\ 0\\.04240092252434357\ \(0\)\
\-\ woman\\:\\ 0\\.041834822177506704\ \(0\)\
\-\ small\\:\\ 0\\.041435627383620686\ \(0\)\
\-\ well\\:\\ 0\\.03889496919127313\ \(0\)\
\-\ female\\:\\ 0\\.03876172141496462\ \(0\)\
\-\ presents\\:\\ 0\\.03864167156427638\ \(0\)\
\-\ treatment\\:\\ 0\\.03826424831009119\ \(0\)\
\-\ also\\:\\ 0\\.037783751644495114\ \(0\)\
\-\ normal\\:\\ 0\\.03279717770062631\ \(0\)\
\-\ at\\:\\ 0\\.030340711882683186\ \(0\)\
\-\ pain\\:\\ 0\\.028744133964753168\ \(0\)\
\-\ this\\:\\ 0\\.027601973954320114\ \(0\)\
\-\ for\\:\\ 0\\.02434664732837361\ \(0\)\
\-\ to\\:\\ 0\\.02008171603002417\ \(0\)\
\-\ in\\:\\ 0\\.019982873865315054\ \(0\)\
\-\ and\\:\\ 0\\.016598693451523157\ \(0\)\
\-\ the\\:\\ 0\\.016028245946491583\ \(0\)\
\-\ with\\:\\ 0\\.01572912781590847\ \(0\)\
